Recombinant activated factor VII for life-threatening pulmonary hemorrhage after pediatric cardiac surgery

Pediatric Critical Care Medicine

Volumn 4, Issue 4, 2003, Pages 444-446

  Leibovitch, Leah ^a   Kenet, Gili ^a   Mazor, Kineret ^a   Matok, Ilan ^a   Vardi, Amir ^a   Barzilay, Zohar ^a   Paret, Gideon ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Activated factor seven; Cardiac surgery; Pulmonary hemorrhage

Indexed keywords

BLOOD CLOTTING FACTOR 7; RECOMBINANT FVIIA; RECOMBINANT PROTEIN;

ARTICLE; CASE REPORT; DOWN SYNDROME; FEMALE; HEART SURGERY; HUMAN; INFANT; LUNG DISEASE; POSTOPERATIVE HEMORRHAGE;

CARDIAC SURGICAL PROCEDURES; DOWN SYNDROME; FACTOR VII; FEMALE; HUMANS; INFANT; LUNG DISEASES; POSTOPERATIVE HEMORRHAGE; RECOMBINANT PROTEINS;

EID: 0842268242     PISSN: 15297535     EISSN: 19473893     Source Type: Journal    
DOI: 10.1097/01.PCC.0000074276.20537.0A     Document Type: Article

References (12)

1. Shapiro AD: Recombinant factor VIIa in the treatment of bleeding in hemophilic children with inhibitors. Semin Thromb Hemost 2000; 26:413-419
2. Hedner U: Recombinant activated factor VII as a universal haemostatic agent. Blood Coagul Fibrinolysis 1998; 9(Suppl 1): S147-S152
3. Hedner U: Recombinant factor VIIa (NovoSeven) as a hemostatic agent. Semin Hematol 2001; 38(4 Suppl 12):43-47
4. Martinowitz U, Kenet G, Segal E, et al: Recombinant activated factor VII for adjunctive hemorrhage control in trauma. J Trauma 2001; 51:431-438
5. Erhardsen E: Pharmacokinetics of recombinant activated factor VII. Semin Thromb Hemost 2000; 26:385-392
6. Jurlander B, Thim L, Klausen NK, et al: Recombinant activated factor VII (rFVIIa): Characterization, manufacturing, and clinical development. Semin Thromb Hemost 2001; 27:373-383
7. van't Veer C, Mann KG: The regulation of the factor VII-dependent coagulation pathway: Rationale for the effectiveness of recombinant factor VIIa in refractory bleeding disorders. Semin Thromb Hemost 2000; 26:367-372
8. Blatt J, Gold SH, Wiley JM, et al: Off-label use of recombinant factor VIIa in patients following bone marrow transplantation. Bone Marrow Transplant 2001; 28:405-407
9. Negrier C, Lienhart A: Overall experience with NovoSeven. Blood Coagul Fibrinolysis 2000; 11(Suppl 1):S19-S24
10. Roberts HR: Recombinant factor VIIa (NovoSeven) and the safety of treatment. Semin Hematol 2001; 38(4 Suppl 12):48-50
11. Chuamshumrit A, Nuntnaraumit P, Okascharoen C, et al: The use of recombinant activated factor VII to control bleeding in a preterm infant undergoing explorative laparotomy. Pediatrics 2002; 107:169-171
12. Veldman A, Fischer D, Burkhard V, et al: Life threatening hemorrhage in neonates: Management with recombinant activated factor VII. Intensive Care Med 2002; 28:1635-1637